Literature DB >> 10823878

Simian immunodeficiency viruses of diverse origin can use CXCR4 as a coreceptor for entry into human cells.

S M Owen1, S Masciotra, F Novembre, J Yee, W M Switzer, M Ostyula, R B Lal.   

Abstract

Primary simian immunodeficiency virus (SIV) isolated from sooty mangabey (SIVsm [n = 6]), stumptail (SIVstm [n = 1]), mandrill (SIVmnd [n = 1]), and African green (SIVagm [n = 1]) primates were examined for their ability to infect human cells and for their coreceptor requirements. All isolates infected human peripheral blood mononuclear cells (PBMCs) from a CCR5(+/+) donor, and seven of eight isolates tested also infected CCR5(-/-) PBMCs. Analysis of coreceptor utilization using GHOST and U87 cell lines revealed that all of the isolates tested used CCR5 and the orphan receptors STRL33 and GPR15. Coreceptors such as CCR2b, CCR3, CCR8, and CX3CR1 were also utilized by some primary SIV isolates. More importantly, we found that CXCR4 was used as a coreceptor by the SIVstm, the SIVagm, and four of the SIVsm isolates in GHOST and U87 cells. These data suggest that primary SIV isolates from diverse primate species can utilize CXCR4 for viral entry, similar to what has been described for human immunodeficiency viruses.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10823878      PMCID: PMC112058          DOI: 10.1128/jvi.74.12.5702-5708.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  46 in total

1.  Patterns of CCR5, CXCR4, and CCR3 usage by envelope glycoproteins from human immunodeficiency virus type 1 primary isolates.

Authors:  H A Bazan; G Alkhatib; C C Broder; E A Berger
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

2.  Genetic subtype-independent inhibition of human immunodeficiency virus type 1 replication by CC and CXC chemokines.

Authors:  A Trkola; W A Paxton; S P Monard; J A Hoxie; M A Siani; D A Thompson; L Wu; C R Mackay; R Horuk; J P Moore
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

3.  Genetically divergent strains of human immunodeficiency virus type 2 use multiple coreceptors for viral entry.

Authors:  S M Owen; D Ellenberger; M Rayfield; S Wiktor; P Michel; M H Grieco; F Gao; B H Hahn; R B Lal
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

4.  Coreceptor usage of human immunodeficiency virus type 2 primary isolates and biological clones is broad and does not correlate with their syncytium-inducing capacities.

Authors:  C Guillon; M E van der Ende; P H Boers; R A Gruters; M Schutten; A D Osterhaus
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

Review 5.  The function of simian chemokine receptors in the replication of SIV.

Authors:  P A Marx; Z Chen
Journal:  Semin Immunol       Date:  1998-06       Impact factor: 11.130

6.  Primary SIVsm isolates use the CCR5 coreceptor from sooty mangabeys naturally infected in west Africa: a comparison of coreceptor usage of primary SIVsm, HIV-2, and SIVmac.

Authors:  Z Chen; A Gettie; D D Ho; P A Marx
Journal:  Virology       Date:  1998-06-20       Impact factor: 3.616

7.  The simian immunodeficiency virus mnd(GB-1) strain uses CXCR4, not CCR5, as coreceptor for entry in human cells.

Authors:  D Schols; E De Clercq
Journal:  J Gen Virol       Date:  1998-09       Impact factor: 3.891

8.  Adaptation to promiscuous usage of CC and CXC-chemokine coreceptors in vivo correlates with HIV-1 disease progression.

Authors:  L Xiao; D L Rudolph; S M Owen; T J Spira; R B Lal
Journal:  AIDS       Date:  1998-09-10       Impact factor: 4.177

9.  Primary human immunodeficiency virus type 2 (HIV-2) isolates infect CD4-negative cells via CCR5 and CXCR4: comparison with HIV-1 and simian immunodeficiency virus and relevance to cell tropism in vivo.

Authors:  J D Reeves; S Hibbitts; G Simmons; A McKnight; J M Azevedo-Pereira; J Moniz-Pereira; P R Clapham
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

10.  A broad range of chemokine receptors are used by primary isolates of human immunodeficiency virus type 2 as coreceptors with CD4.

Authors:  A McKnight; M T Dittmar; J Moniz-Periera; K Ariyoshi; J D Reeves; S Hibbitts; D Whitby; E Aarons; A E Proudfoot; H Whittle; P R Clapham
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

View more
  15 in total

1.  The well-tempered SIV infection: Pathogenesis of SIV infection in natural hosts in the wild, with emphasis on virus transmission and early events post-infection that may contribute to protection from disease progression.

Authors:  Kevin Raehtz; Ivona Pandrea; Cristian Apetrei
Journal:  Infect Genet Evol       Date:  2016-07-06       Impact factor: 3.342

Review 2.  Going wild: lessons from naturally occurring T-lymphotropic lentiviruses.

Authors:  Sue VandeWoude; Cristian Apetrei
Journal:  Clin Microbiol Rev       Date:  2006-10       Impact factor: 26.132

3.  In vitro characterization of primary SIVsmm isolates belonging to different lineages. In vitro growth on rhesus macaque cells is not predictive for in vivo replication in rhesus macaques.

Authors:  Rajeev Gautam; Anders Chase Carter; Nathalia Katz; Isolde F Butler; Mary Barnes; Atsuhiko Hasegawa; Marion Ratterree; Guido Silvestri; Preston A Marx; Vanessa M Hirsch; Ivona Pandrea; Cristian Apetrei
Journal:  Virology       Date:  2007-02-15       Impact factor: 3.616

4.  Derivation and characterization of a simian immunodeficiency virus SIVmac239 variant with tropism for CXCR4.

Authors:  Gregory Q Del Prete; Beth Haggarty; George J Leslie; Andrea P O Jordan; Josephine Romano; Nathaniel Wang; Jianbin Wang; Michael C Holmes; David C Montefiori; James A Hoxie
Journal:  J Virol       Date:  2009-07-15       Impact factor: 5.103

5.  Detection of simian immunodeficiency virus in diverse species and of human immunodeficiency virus Type 2 by using consensus primers within the pol region.

Authors:  Silvina Masciotra; Chunfu Yang; Danuta Pieniazek; Chanda Thomas; Sherry M Owen; Harold M McClure; Renu B Lal
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

6.  Simian Immunodeficiency Virus SIVagm Efficiently Utilizes Non-CCR5 Entry Pathways in African Green Monkey Lymphocytes: Potential Role for GPR15 and CXCR6 as Viral Coreceptors.

Authors:  Nadeene E Riddick; Fan Wu; Kenta Matsuda; Sonya Whitted; Ilnour Ourmanov; Simoy Goldstein; Robert M Goeken; Ronald J Plishka; Alicia Buckler-White; Jason M Brenchley; Vanessa M Hirsch
Journal:  J Virol       Date:  2015-12-09       Impact factor: 5.103

7.  Polymorphism of human and primate RANTES, CX3CR1, CCR2 and CXCR4 genes with regard to HIV/SIV infection.

Authors:  Bénédicte Puissant; Michel Abbal; Antoine Blancher
Journal:  Immunogenetics       Date:  2003-07-23       Impact factor: 2.846

8.  Bovine immunodeficiency virus expression in vitro is reduced in the presence of beta-chemokines, MIP-1alpha, MIP-1beta and RANTES.

Authors:  S M Wright; A Mleczko; K S Coats
Journal:  Vet Res Commun       Date:  2002-04       Impact factor: 2.459

9.  A single amino acid difference in the host APOBEC3G protein controls the primate species specificity of HIV type 1 virion infectivity factor.

Authors:  Hal P Bogerd; Brian P Doehle; Heather L Wiegand; Bryan R Cullen
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-03       Impact factor: 11.205

10.  Engineered CD4- and CXCR4-using simian immunodeficiency virus from African green monkeys is neutralization sensitive and replicates in nonstimulated lymphocytes.

Authors:  Renate R König; Egbert Flory; Stefanie Steidl; Jeanette Neumann; Cheick Coulibaly; Edgar Holznagel; Silke Holzammer; Stephen Norley; Klaus Cichutek
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.